Home / Science Says! / N169 A Healthy Fat Score: Welcome To The Club, C15:0
Previous Mailing Back

Science Says!

N-169

A Healthy Fat Score: Welcome To The Club, C15:0

March 1, 2026
Foods that are healthy fats

Welcome to Issue 169 of Science Says! Our weekly newsletter where you’ll learn the latest healthy aging and C15:0 research news that our team of doctors, scientists, and experts are most excited about—without having to go search for it.

Eric and Steph
Co-Founders, Doctors, Nerds

stephanie

What Dr. Stephanie Venn-Watson, our co-founder and author of The Longevity Nutrient and over 80 peer-reviewed scientific publications, is reading.

Healthy Aging

A new look at cardiovascular health, where every point counts (including C15:0)

A research team in Barcelona, Spain recently published a blood-based “fat score” that could be used to predict cardiovascular health. While the expected omegas were included as healthy fats, this team also included the new up-and-comers, C15:0 and C17:0. Let’s see what they found.

I’m in. Which specific fatty acids were included in this “fat score”?

Good question. First, Lazaro et al. created two groups, good fats and bad fats. Fatty acids were defined as good vs. bad based on the team’s review of landmark papers that pooled data from many cohorts and identified fatty acids that were positively or negatively associated with cardiovascular health AND also had theoretical/established direct effects on cardiovascular health.

The Good Fat Group:

  • C15:0 + C17:0 (pentadecanoic acid, an emerging essential fatty acid; and heptadecanoic acid. Both are odd-chain saturated fatty acids.)
  • C18:2n-6 (linoleic acid, an essential fatty acid)
  • C18:3n-3 (ɑ-linolenic acid, an essential fatty acid)
  • C20:5n-3 (eicosapentaenoic acid, EPA, an omega-3 fatty acid)
  • C22:6n-3 (docosahexaenoic acid, DHA, an omega3 fatty acid)

The Bad Fat Group:

  • C16:0 (palmitic acid, an even-chain saturated fatty acid)
  • C16:1n-7 (palmitoleic acid, an omega-7 monounsaturated fatty acid)
  • C18:0 (stearic acid, an even-chain saturated fatty acid)

Once Lazaro et al. defined which fatty acids went into each group, they looked at red blood cell membrane fatty acid measurements from 876 adults in Spain (438 cases that had poor cardiovascular health vs. 438 controls that had good cardiovascular health).

The LFQ Score

This blood-based lipidomic fat quality (LFQ) score was determined for each person as follows:

  • Every good fatty acid at levels above the median of the control group got a score of 1. That means if a person had higher levels of all five good fats, they would start with a score of 5.
  • Every bad fatty acid at levels below the median of the control group also got a score of 1. That means if a person had lower levels of all three bad fats, they would get an additional 3 points.

Thus, the range of the LFQ score was 0-8.

Got it. So, what did they find?

Well, for every 1-unit increase in the LFQ score, the risk of poor cardiovascular health was decreased by 14%. When comparing people who had low scores (0-3 points) vs. high scores (5-8 points), those with the high scores had a 36% lower risk of having poor cardiovascular health.

We like those odds.

C15:0’s active role in supporting cardiovascular health

A few weeks back, we applied the Bradford Hill Criteria of Causality (which use real-world and experimental data to infer causation, not just association) to support C15:0 as an active nutrient that protects our long-term health, including our cardiovascular health.

This evidence, specific to cardiovascular health, included the following:

  • Strength of association: Higher C15:0 has been associated with a lower risk of developing cardiovascular diseases, with lower risks ranging from 12% to 25%.
  • Consistency: The consistent protective direction of C15:0 is consistent across European, Asian, and US cohorts from 2010-2025.
  • Specificity: Evidence includes odd-chain versus even-chain saturated fatty acid differential effects.
  • Temporality: ALL studies prospectively measured baseline C15:0 levels before cardiovascular events occurred.
  • Dose-response curves: Dose-response meta-analyses and linear gradient relationships have been well documented, showing that the higher the C15:0 level, the greater the benefit.
  • Biological plausibility: Mechanistic evidence has been provided that C15:0 lowers pro-inflammatory cytokines relevant to cardiovascular health.
  • Coherence: Epidemiologic and mechanistic findings align with broader nutrition data indicating that odd-chain fatty acids and dairy-fat biomarkers are linked to favorable cardiovascular health outcomes and aligns with known pathophysiology.
  • Experiment: Animal supplementation and dairy intervention studies demonstrate causal cardiovascular health benefits.
  • Analogy: C17:0, another odd-chain saturated fatty acid, has shown similar effects. Similar findings for C15:0 and metabolic health also support C15:0’s direct role in protecting cardiometabolic health.

The latest paper by Lazaro et al. continue to support C15:0 as a foundational nutrient that has our backs (and our hearts). Have a fantastic week, everyone!

divider
Previous Mailing Back Previous Mailing Back on top
Download